Physicochemical studies and anticancer potency of ruthenium η6-p-cymene complexes containing antibacterial quinolones

112Citations
Citations of this article
79Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

With the aim of exploring the anticancer properties of organometallic compounds with bioactive ligands, Ru(arene) compounds of the antibacterial quinolones nalidixic acid (2) and cinoxacin (3) were synthesized, and their physicochemical properties were compared to those of chlorido(η6- p-cymene)(ofloxacinato-κ2O,O)ruthenium(II) (1). All compounds undergo a rapid ligand exchange reaction from chlorido to aqua species. 2 and 3 are significantly more stable than 1 and undergo minor conversion to an unreactive [(cym)Ru(μ-OH)3Ru(cym)]+ species (cym = η6-p-cymene). In the presence of human serum albumin 1-3 form adducts with this transport protein within 20 min of incubation. With guanosine 5'-monophosphate (5'-GMP; as a simple model for reactions with DNA) very rapid reactions yielding adducts via its N7 atom were observed, illustrating that DNA is a possible target for this compound class. A moderate capacity of inhibiting tumor cell proliferation in vitro was observed for 1 in CH1 ovarian cancer cells, whereas 2 and 3 turned out to be inactive. © 2011 American Chemical Society.

Cite

CITATION STYLE

APA

Kljun, J., Bytzek, A. K., Kandioller, W., Bartel, C., Jakupec, M. A., Hartinger, C. G., … Turel, I. (2011). Physicochemical studies and anticancer potency of ruthenium η6-p-cymene complexes containing antibacterial quinolones. Organometallics, 30(9), 2506–2512. https://doi.org/10.1021/om101180c

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free